Harrow Eye, LLC
8 drugs in NADAC|0 Generic,8 Brand
Harrow Eye, LLC lists 8 NDCs in the CMS NADAC file (0 generic, 8 brand), at an average NADAC of $91.43 per unit, with a week-over-week move of -0.0% across products that moved. The firm's full portfolio, pricing trend are listed below.
Total Drugs
8
0G / 8B
Avg Price / Unit
$91.4261
$7.35 – $379.87
Avg 7d Change
-0.01%
Across 5 drugs with changes
7d Activity
of 8 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Keep following this manufacturer
These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.
Lead market
nepafenac market
See the molecule this manufacturer shows up in most often and compare it against competing suppliers.
Lead class
Nonsteroidal Anti-inflammatory Drug therapeutic class
Review the broader class where Harrow Eye, LLC has the strongest current portfolio footprint.
Trend hub
Portfolio trend view
Jump to the trend hub to compare this manufacturer against the rest of the market on weekly price movement.
Guide
NADAC pricing primer
Use the explainer for context on the benchmark this manufacturer is being compared against.
Frequently Asked Questions
How many drugs does Harrow Eye, LLC make?
Harrow Eye, LLC lists 8 NDCs in the CMS NADAC file — 0 generic and 8 brand products.
What is the average price of Harrow Eye, LLC drugs?
The average NADAC across Harrow Eye, LLC's portfolio is $91.4261 per unit, ranging from $7.3536 to $379.8730.
What types of drugs does Harrow Eye, LLC make?
Harrow Eye, LLC makes drugs across 7 FDA pharmacologic classes. The most common by NDC count are Nonsteroidal Anti-inflammatory Drug (2), Corticosteroid (2), Calcineurin Inhibitor Immunosuppressant (1), Aminoglycoside Antibacterial (1), Fluoroquinolone Antibacterial (1).
Has Harrow Eye, LLC had any drug recalls?
No FDA enforcement recalls are matched to Harrow Eye, LLC in the openFDA feed.
How has Harrow Eye, LLC's pricing changed recently?
Over the past 7 days, 2 Harrow Eye, LLC products rose and 3 fell, with a portfolio-wide average change of -0.0%.
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
VEVYE 0.1% EYE DROP cyclosporine ophthalmic solution | $379.8730 per ML | — |
ILEVRO 0.3% OPHTH DROPS nepafenac | $121.1431 per ML | -0.03% |
NEVANAC 0.1% EYE DROP nepafenac | $104.7075 per ML | +0.04% |
TOBRADEX ST 0.3-0.05% EYE DROP tobramycin / dexamethasone | $46.6324 per ML | +0.03% |
VIGAMOX 0.5% EYE DROPS moxifloxacin hydrochloride | $31.8080 per ML | — |
IOPIDINE 1% EYE DROP apraclonidine hydrochloride ophthalmic solution | $26.7049 per EA | — |
MAXIDEX 0.1% EYE DROPS dexamethasone | $13.1863 per ML | -0.09% |
ZERVIATE 0.24% EYE DROP cetirizine | $7.3536 per EA | -0.02% |